CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Sanofi

SNY
$50.81BLarge Cap

Next catalyst

PDUFANov 25, 2026in 29 days

Venglustat

Type 3 Gaucher disease

FDA decision pageSource

Get an email about SNY's next catalysts

Track Sanofi (SNY) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.

Plus 46 more upcoming events in our data (Phase 2 readout, earnings, Phase 3 readout).See the timeline

Catalyst Timeline

47 upcoming, 2 past

Phase 2

venglustat (GZ402671) Phase 2 Est. Readout

October 2026~Venglustat (GZ402671)12

Primary completion for venglustat (GZ402671) trial (NCT02843035) in Gaucher Disease Type 1

Source
Earnings

SNY Earnings Report

Oct 30, 2026

EPS Est: $1.63 | FQ end Sep/2026 | Call: bmo

Phase 2

Isatuximab Phase 2 Est. Readout (UltraFrailMM)

November 2026~Isatuximab40

Estimated primary completion for Isatuximab trial (NCT06517017) in Multiple Myeloma. Topline data typically follows completion by weeks to months.

Source
PDUFANext

FDA PDUFA Date Venglustat

Nov 25, 2026Venglustat

For Type 3 Gaucher disease. NDA, Priority Review. Verified against the company announcement on 2026-10-16.

Source
Phase 3

Measles, combinations with mumps and rubella, live attenuated Phase 3 Est. Readout

November 2026~Measles, combinations with mumps and rubella, live attenuated2,440

Estimated primary completion for Measles, combinations with mumps and rubella, live attenuated trial (NCT07103148) in Yellow Fever Immunization. Topline data typically follows completion by weeks to months.

Source
Phase 3

rilzabrutinib Phase 3 Est. Readout

Q4 2026~QRilzabrutinib4

Primary completion for rilzabrutinib trial (NCT07216079) in Immune Thrombocytopenia

Source
Phase 3

PCV21 Phase 3 Est. Readout

December 2026~PCV211,268

Estimated primary completion for PCV21 trial (NCT06838000) in Pneumococcal Infections. Topline data typically follows completion by weeks to months.

Source
Phase 2

Pandemic flu H5 HA mRNA SD2 vaccine Phase 2 Est. Readout

December 2026~Pandemic flu H5 HA mRNA SD2 vaccine720

Estimated primary completion for Pandemic flu H5 HA mRNA SD2 vaccine trial (NCT06907511) in Pandemic Influenza Immunization. Topline data typically follows completion by weeks to months.

Source

Upcoming FDA decisions

How SNY's past catalysts played out

PDUFA decisionMar 2020+11%OtherJun 2016-7%

Market Overview

Stock performance and key metrics

NASDAQPharmaceutical PreparationsPharmaceuticals🇺🇸EuropePARIS82.9K employees

Sanofi S.A. is a French multinational pharmaceutical and healthcare company headquartered in Paris. The corporation was established in 1973 and merged with Synthélabo in 1999 to form Sanofi-Synthélabo. In 2004, Sanofi-Synthélabo merged with Aventis and renamed to Sanofi-Aventis, which were each the product of several previous mergers. It changed its name back to Sanofi in May 2011. The company trades as "SAN" on Euronext Paris and "SNY" on Nasdaq in the United States, and is a component of the Euro Stoxx 50 stock market index. In 2023, the company was ranked 89th in the Forbes Global 2000.

Website
Drug Pipeline

INSULIN GLARGINE/LIXISENATIDE (HOE901/AVE0010)

Phase 3

Type 2 Diabetes Mellitus

escitalopram

Phase 3

Depressive Disorder

Meningococcal Polysaccharide (Serogroups A, C, Y, and W) Tetanus Toxoid Conjugate Vaccine (MenACYW Conjugate vaccine)

Phase 3

Meningococcal Immunisation

Inactive Poliovirus Vaccine

Phase 3

Poliomyelitis

Moisturizers

Phase 3

Neurodermatitis

Itepekimab SAR440340

Phase 3

Chronic Obstructive Pulmonary Disease

Insulin monotherapy with premixed insulin NPH 30/70

Phase 3

Diabetes Mellitus, Type 2

Topical calcineurin inhibitors

Phase 3

Dermatitis Atopic

Meningococcal polysaccharide (serogroups A,C,Y and W-135) diphtheria toxoid conjugate vaccine

Phase 3

Meningococcal Immunization

Sarilumab

Phase 3

RA

Oral bivalent types 1 and 3; Poliomyelitis Vaccine (OPV)

Phase 3

Meningococcal Immunisation

Inactivated, split-virion influenza vaccine

Phase 3

Orthomyxoviridae Infection

HBVAXPRO

Phase 3

Virus Diseases

rFIXFc

Phase 3

Hemophilia B

sutimlimab (BIVV009)

Phase 3

Cold Agglutinin Disease

Antidiabetic background therapy

Phase 3

Type 2 Diabetes

Glucocorticoid

Phase 3

Immunoglobulin G4 Related Disease

Vandetanib (SAR390530)

Phase 3

Differentiated Thyroid Cancer

Itepekimab (SAR440340)

Phase 3

Chronic Obstructive Pulmonary Disease

Imiglucerase

Phase 3

Gaucher Disease, Type 1

Zolpidem (SL800750)

Phase 3

Attention Deficit Hyperactivity Disorder

LACTIC ACID(ND)

Phase 3

Hygiene

Quadrivalent Inactivated Influenza Vaccine (2016-2017 NH formulation), No Preservative

Phase 3

Influenza

Riliprubart

Phase 3

Chronic Inflammatory Demyelinating Polyradiculoneuropathy

teriflunomide (HMR1726)

Phase 3

Multiple Sclerosis

Semuloparin Sodium

Phase 3

Venous Thromboembolism

Yellow fever vaccine

Phase 3

Yellow Fever

paroxetine

Phase 3

Depressive Disorder, Major

xaliproden (SR57746A)

Phase 3

Alzheimer Disease

Diphtheria, Tetanus, Polio, Acellular Pertussis and Hib

Phase 3

Diphtheria

Sulfasalazine

Phase 3

Rheumatoid Arthritis

GEMIGLIPTIN LS15-0444

Phase 3

Type 2 Diabetes Mellitus

Idrabiotaparinux sodium

Phase 3

Deep Venous Thrombosis

MRI contrast-enhancing preparations

Phase 3

Multiple Sclerosis

FOLFIRI (Irinotecan, 5-Fluorouracil, and Leucovorin)

Phase 3

Colorectal Neoplasms

afuzosin

Phase 3

Benign Prostatic Hyperplasia

Fexofenadine M016455

Phase 3

Rhinitis Seasonal

Iniparib

Phase 3

Primary Peritoneal Cancer

rFVIIIFc

Phase 3

Hemophilia A

Doxorubicine + docetaxel sequential

Phase 3

Breast Neoplasms

SENNA+CASSIA(Naturetti)

Phase 3

Constipation

Antithrombin concentrate (ATIIIC)

Phase 3

Hemophilia

RSVt vaccine

Phase 3

RSV Immunization

Insulin human/Insuman Comb 25 (HR1799)

Phase 3

Type 2 Diabetes Mellitus

Infanrix® -IPV+Hib

Phase 3

Pertussis

SR123781A

Phase 3

Venous Thromboembolism

Prednisone (or Prednisolone)

Phase 3

Prostate Cancer

Influenza Virus Vaccine USP Trivalent Types A and B

Phase 3

Orthomyxoviridae Infection

DTaP-IPV-Hep B- PRP~T + Prevenar + Rotarix vaccine

Phase 3

Diphtheria

Sulfonylurea

Phase 3

Type 2 Diabetes Mellitus

Quadrivalent Influenza Vaccine (split virion, inactivated)

Phase 3

Influenza

Live, attenuated, recombinant dengue serotypes 1, 2, 3, and 4 virus

Phase 3

Dengue Fever

Oxaliplatin + 5-Fluorouracil/Leucovorin

Phase 3

Carcinoma, Hepatocellular

Investigational Quadrivalent Inactivated Influenza Vaccine, No Preservative

Phase 3

Influenza

DTaP-IPV combined vaccine

Phase 3

Pertussis

FluCAM [Fludara + Campath]

Phase 3

B-Cell Chronic Lymphocytic Leukemia

paracetamol paediatric

Phase 3

Fever

DTaP-HB PRP~T Combined Vaccine

Phase 3

Diphtheria

Lactic Acid (Dermacyd PH_DETINBACK Tangerine Mix)

Phase 3

Hygiene

Glutamine

Phase 3

Colorectal Neoplasms

Insulin glargine U300 (new formulation of insulin glargine) HOE901

Phase 3

Diabetes Mellitus Type 2

FluBlok®

Phase 3

Influenza

NPH human insulin

Phase 3

Diabetes Mellitus, Type 2

Fabrazyme (agalsidase beta)

Phase 3

Fabry Disease

Pneumo 23

Phase 3

Streptococcus Pneumoniae

Insulin glargine (HOE901)

Phase 3

Type 2 Diabetes Mellitus

amiodarone

Phase 3

Atrial Fibrillation

CELIVARONE (SSR149744C)

Phase 3

Atrial Fibrillation

Meningococcal polysaccharide (serogroups A, C, Y, and W) tetanus toxoid Conjugate vaccine MenACYW Conjugate vaccine

Phase 3

Meningococcal Immunisation (Healthy Volunteers)

Thyrogen (thyrotropin alfa for injection)

Phase 3

Differentiated Thyroid Cancer

Dermacyd PH_DETINLYN Sweet Flower (Lactic Acid)

Phase 3

Hygiene

Exenatide

Phase 3

Diabetes Mellitus, Type 2

CABAZITAXEL (XRP6258)

Phase 3

Prostatic Neoplasms

Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed Tdap (ADACEL)

Phase 3

Diphtheria

Cholestyramine

Phase 3

Multiple Sclerosis

Prevnar 20 vaccine

Phase 3

Pneumococcal Immunization

Cisplatin, 5-fluorouracil (5-FU), radiotherapy

Phase 3

Head and Neck Neoplasms

Humalog

Phase 3

Type 1 Diabetes Mellitus

Docetaxel, Cisplatin, 5-fluorouracil (5-FU), radiotherapy

Phase 3

Head and Neck Neoplasms

Live, attenuated, dengue serotype 1, 2, 3, 4 virus

Phase 3

Dengue

Teriflunomide HMR1726

Phase 3

Relapsing Multiple Sclerosis

Alirocumab SAR236553

Phase 3

Hypercholesterolaemia

Meningococcal polysaccharide groups A, C, W-135 and Y Conjugate vaccine

Phase 3

Meningitis

Isatuximab SAR650984

Phase 3

Multiple Myeloma

rhIDU (recombinant human-Alpha-L-Iduronidase)

Phase 3

Mucopolysaccharidosis I

Meningococcal Polysaccharide (Serogroups A, C, Y, and W) Tetanus Toxoid Conjugate Vaccine

Phase 3

Meningitis

Meningococcal polysaccharide (serogroups A,C,Y and W) tetanus toxoid conjugate vaccine MenACYW conjugate vaccine

Phase 3

Healthy Volunteers (Meningococcal Infection)

CYD Dengue vaccine

Phase 3

Dengue Fever

Teriflunomide

Phase 3

Multiple Sclerosis

Influenza Virus Vaccine

Phase 3

Influenza

Hexaxim®

Phase 3

Diphtheria

Rotavirus Vaccine, Live, Pentavalent

Phase 3

Healthy Volunteers (Meningococcal Infection)

JE-VAX®

Phase 3

Japanese Encephalitis

Eliglustat GZ385660

Phase 3

Gaucher's Disease Type I

Venglustat

Phase 3

Gaucher's Disease Type III

Avalglucosidase alfa (GZ402666)

Phase 3

Glycogen Storage Disease Type II;Pompe's Disease

gemcitabine/Eloxatin (GEMOX)

Phase 3

Carcinoma, Non-Small-Cell Lung

aflibercept

Phase 3

Colorectal Neoplasms

Corticosteroids

Phase 3

Thrombotic Thrombocytopenic Purpura

Insulin glargine (U300)

Phase 3

Type 2 Diabetes Mellitus

Prevenar 13®

Phase 3

Neisseria Meningitidis

Concomitant administration

Phase 3

Diphtheria

Diphteria, tetanus, and Acellular Pertussis vaccine

Phase 3

Diphtheria

Tocilizumab

Phase 3

Rheumatoid Arthritis

Alirocumab

Phase 3

Hypercholesterolemia

Dermacyd Femina Pocket BR (Lactic Acid)

Phase 3

Hygiene

M-M-R II vaccine

Phase 3

Pneumococcal Immunization

docetaxel, doxorubicin, cyclophosphamide

Phase 3

Breast Cancer

JE-CV Vaccine

Phase 3

Japanese Encephalitis

PVRV

Phase 3

Rabies

Meningococcal Group C Conjugate vaccine: MenC

Phase 3

Meningitis

S-1 (1-(2-tetrahydrofuryl)-5-fluorouracil + 5-chloro-2, 4-dihydroxypyridine (CDHP) (Gimeracil) + Oxo (Oteracil)

Phase 3

Gastric Cancer

Diphtheria and Tetanus Toxoids and Acellular Pertussis + Measles, Mumps, Rubella + Varicella Virus

Phase 3

Tetanus

Purified vero rabies vaccine - serum free VRVg-2

Phase 3

Rabies (Healthy Volunteers)

Shanchol™: Oral Cholera Vaccine Killed Bivalent (O1 and O139) Whole Cell

Phase 3

Cholera

QIV-HD

Phase 3

Influenza

ChimeriVax™-JE

Phase 3

Japanese Encephalitis

DTaP-IPV-HB-PRP~T vaccine

Phase 3

Diphtheria

Spores of Bacillus Clausii Probiotic Strain

Phase 3

Diarrhea

REPEVAX

Phase 3

Healthy

Human Papillomavirus Quadrivalent [Types 6, 11, 16, and 18] Vaccine, Recombinant

Phase 3

Dengue Fever

PEDIACEL® and Prevenar®

Phase 3

Diphtheria

Oral anti-diabetic drugs

Phase 3

Type 2 Diabetes Mellitus

Tdap: Tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine adsorbed

Phase 3

Tetanus

ZD6474 (vandetanib)

Phase 3

Thyroid Cancer

Live, attenuated dengue serotype 1, 2, 3, and 4 virus

Phase 3

Dengue

SARS-CoV-2 recombinant protein vaccine Phase 2 Formulation 1

Phase 3

COVID-19

omega-3 polyunsaturated fatty acids (PUFA)

Phase 3

Diabetes Mellitus, Non-Insulin-Dependent

acetylsalicyclic acid (ASA)

Phase 3

Acute Coronary Disease

Bacillus Clausii

Phase 3

Gastroenteritis

High-Dose Quadrivalent Influenza Vaccine

Phase 3

Influenza (Healthy Volunteers)

Meningococcal (Groups A, C, Y and W 135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine

Phase 3

Meningitis

SAR153191 (REGN88)

Phase 3

Rheumatoid Arthritis

Non sedating H1-antihistamine

Phase 3

Cold Urticaria

Dermacyd Breeze Pocket BR (Lactic Acid)

Phase 3

Hygiene

Meningococcal Diphtheria Toxoid Vaccine

Phase 3

Meningitis

Insulin aspart

Phase 3

Type 1 Diabetes Mellitus-Type 2 Diabetes Mellitus

Alfuzosin

Phase 3

Acute Urinary Retention

saredutant (SR48968)

Phase 3

Major Depressive Disorder

HDCV

Phase 3

Healthy Volunteers (Rabies Immunization)

High-Dose trivalent influenza vaccine (Split virion, Inactivated)

Phase 3

Influenza

Docetaxel/DDP

Phase 3

Lung Neoplasms

Tritanrix-HepB/Hib

Phase 3

Diphtheria

riferminogene pecaplasmid

Phase 3

Peripheral Vascular Diseases

Isatuximab

Phase 3

Plasma Cell Myeloma Refractory

Sargramostim (Leukine)

Phase 3

Crohn Disease

lixisenatide AVE0010

Phase 3

Type 2 Diabetes Mellitus

Meningococcal (Groups A, C, Y and W 135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine

Phase 3

Healthy Volunteers (Meningococcal Infection)

DTwP-HepB-Hib-IPV hexavalent vaccine (Diphtheria toxoid, Tetanus toxoid, whole cell pertussis, Hepatitis B surface antigen (HBsAg), Haemophilus influenzae type b, inactivated poliovirus)

Phase 3

Pertussis Immunisation

Japanese encephalitis vaccine

Phase 3

Japanese Encephalitis

Caplacizumab (ALX-0081)

Phase 3

Thrombotic Thrombocytopenic Purpura

Quadrivalent Influenza Vaccine

Phase 3

Influenza

Sarilumab SAR153191

Phase 3

Corona Virus Infection

Amlitelimab

Phase 3

Dermatitis Atopic

sodium hyaluronate

Phase 3

Osteoarthritis of Shoulder

Insulin glargine U100 (HOE901)

Phase 3

Type 2 Diabetes Mellitus

Docetaxel (TAXOTERE®) Chemotherapy

Phase 3

Prostatic Neoplasms

Inhaled Long-Acting Beta Agonist

Phase 3

Chronic Obstructive Pulmonary Disease

Saredutant (SR48968C)

Phase 3

Depressive Disorder

insulin lispro

Phase 3

Diabetes Mellitus, Insulin-Dependent

Quadrivalent Recombinant influenza vaccine (RIV4) season/2022-2023/NH

Phase 3

Influenza Immunization

IVIg

Phase 3

Chronic Inflammatory Demyelinating Polyneuropathy

Levofloxacin

Phase 3

Prostatitis

Tdap (Tetanus Toxoid Reduced Diphtheria Toxoid/Acellular Pertussis)

Phase 3

Tetanus

High-Dose Inactivated, Split-Virion Influenza Vaccine

Phase 3

Orthomyxoviridae Infection

DTaP//PRP-T Combined Vaccine

Phase 3

Diphtheria

Hexavalent vaccine

Phase 3

Neisseria Meningitidis

Rasburicase (SR29142)

Phase 3

Hyperuricemia

Diphtheria, Tetanus, Pertussis (Acellular, Component) Poliomyelitis (inactivated) Vaccine, and Haemophilus influenza type b Conjugate Vaccine

Phase 3

Healthy Volunteers (Meningococcal Infection)

IMOJEV

Phase 3

Japanese Encephalitis

Venglustat (GZ402671)

Phase 3

Fabry Disease

Clopidogrel (Iscover/Plavix)

Phase 3

Myocardial Infarction

RotaTeq®

Phase 3

Neisseria Meningitidis

triamcinolone XRG5029

Phase 3

Rhinitis Allergic

lormetazepam

Phase 3

Sleep Initiation and Maintenance Disorders

zolpidem-MR (modified release)

Phase 3

Sleep Initiation and Maintenance Disorders

5-fluorouracil

Phase 3

Breast Cancer

Non-statin LMT

Phase 3

Hypercholesterolemia

Diphtheria, tetanus, pertussis (acellular component), hepatitis B, poliomyelitis (inactivated), and Haemophilus influenzae type b conjugate vaccine

Phase 3

Healthy Volunteers (Meningococcal Infection)

Live attenuated Japanese encephalitis chimeric virus vaccine

Phase 3

Japanese Encephalitis

Iniparib (SAR240550/BSI-201)

Phase 3

Solid Tumors

DTaP-IPV//PRP~T combined vaccine

Phase 3

Diphtheria

Aldurazyme

Phase 3

Mucopolysaccharidosis I

Live, attenuated, recombinant dengue serotype 1, 2, 3, and 4 virus

Phase 3

Dengue

Ciclesonide (XRP1526)

Phase 3

Asthma

alemtuzumab

Phase 3

B Cell Chronic Lymphocytic Leukemia

Pediacel®

Phase 3

Neisseria Meningitidis

NeisVac-C®

Phase 3

Neisseria Meningitidis

epidoxorubicine, ciclophosphamide, methotrexate, fluorouracile

Phase 3

Breast Neoplasms

Telithromycin (HMR3647)

Phase 3

Pneumonia

Topical corticosteroids

Phase 3

Dermatitis Atopic

Insulin Aspart SAR341402

Phase 3

Type 1 Diabetes Mellitus

Caplacizumab

Phase 3

Acquired Thrombotic Thrombocytopenic Purpura

Plerixafor

Phase 3

Multiple Myeloma

volinanserin (M100907)

Phase 3

Sleep Initiation and Maintenance Disorders

SAR408701

Phase 3

Non-small Cell Lung Cancer Metastatic

Insulin Glargine (HOE901 - U300)

Phase 3

Type 2 Diabetes Mellitus

Dexamethasone (pre- and post-medication for docetaxel)

Phase 3

Carcinoma

Docetaxel (Taxotere®)

Phase 3

Ovarian Cancer

dianicline

Phase 3

Smoking

Insulin glargine (HOE901) (Lantus)

Phase 3

Type 1 Diabetes Mellitus

FDC KETOPROFEN+OMEPRAZOLE

Phase 3

Pain

Clotting factor concentrates (CFC) or bypassing agents (BPA)

Phase 3

Hemophilia

Pentacel™: HCPDT-IPV//PRP-T Vaccine and Prevnar®

Phase 3

Diphtheria

HBVaxPRO®

Phase 3

Hepatitis B

DAPTACEL®. (DTaP), IPOL®., and ActHIB®

Phase 3

Diphtheria

Menactra®: Meningococcal A, C, Y, and W 135 Polysaccharide Diphtheria Toxoid Conjugate vaccine

Phase 3

Neisseria Meningitidis

BIVV009

Phase 3

Agglutinin Disease, Cold

irbesartan/amlodipine

Phase 3

Hypertension

Triamcinolone

Phase 3

Rhinitis, Allergic, Perennial

Glycerine Vegetal Soap Granado Traditional

Phase 3

Hygiene

Asthma Controller Therapies

Phase 3

Asthma

Granulocyte-colony stimulating factor (G-CSF)

Phase 3

Non-Hodgkin's Lymphoma

Interferon beta-1a

Phase 3

Multiple Sclerosis, Relapsing-Remitting

larotaxel (RPR109881, XRP9881)

Phase 3

Breast Cancer

SR48692

Phase 3

Lung Cancer

Lipid Modifying Therapy (LMT)

Phase 3

Hypercholesterolemia

larotaxel (XRP9881)

Phase 3

Advanced Breast Cancer

SR121463B

Phase 3

Inappropriate ADH Syndrome

Enoxaparin sodium (XRP4563)

Phase 3

Myocardial Infarction

clofarabine

Phase 3

Acute Lymphoblastic Leukemia

Asthma Controller Therapies (include prednisone/prednisolone)

Phase 3

Asthma

Low Dose (LD) RSVt vaccine

Phase 3

RSV Immunisation

eplivanserin (SR46349)

Phase 3

Sleep Initiation and Maintenance Disorders

High-Dose Influenza Vaccine (split virion, inactivated), Quadrivalent (QIV-HD) 2019-2020 Northern Hemisphere formulation

Phase 3

Influenza Immunization

PCV21

Phase 3

Pneumococcal Infections

Insulin glargine/lixisenatide fixed ratio combination

Phase 3

Type 2 Diabetes Mellitus

Dermacyd PH_DETINLYN Tangerine Mix (Lactic Acid)

Phase 3

Hygiene

MAXOMAT ®, biosynthetic growth hormone

Phase 3

Noonan Syndrome

Dupilumab (SAR231893/REGN668)

Phase 3

Asthma

zolpidem-MR (SL800750)

Phase 3

Sleep Initiation and Maintenance Disorders

Quadrivalent Recombinant Influenza Vaccine (RIV4)

Phase 3

Influenza (Healthy Volunteers)

Dermacyd PH_DETINLYN (Lactic Acid)

Phase 3

Hygiene

SGLT2 inhibitor

Phase 3

Type 2 Diabetes Mellitus

DAPTACEL® (Diphtheria and Tetanus Toxoids and Acellular Pertussis vaccine)

Phase 3

Diphtheria

Quadrivalent influenza vaccine (QIV) (split virion, inactivated) Northern Hemisphere (NH) 2015-2016

Phase 3

Influenza

insulin secretagogue

Phase 3

Diabetes Mellitus, Type 2

Influenza virus vaccine (split virion, inactivated)

Phase 3

Influenza

hydroxychloroquine (Z0188)

Phase 3

Cutaneous Lupus Erythematosus-Systemic Lupus Erythematosus

MenACYW conjugate vaccine

Phase 3

Meningococcal Infections

Sotagliflozin (SAR439954)

Phase 3

Diabetes Mellitus

ketoprofen

Phase 3

Pain

Typhoid Vi polysaccharide

Phase 3

Salmonella Infections

risedronate (HMR4003)

Phase 3

Osteoporosis, Postmenopausal

Lantus (glargine)

Phase 3

Type 1 Diabetes

Ombrabulin (AVE8062)

Phase 3

Ovarian Cancer Recurrent

anti-CD20 antibody

Phase 3

Thrombotic Thrombocytopenic Purpura

Diphtheria, tetanus, polio and pertussis vaccination

Phase 3

Diphtheria

REVAXIS®

Phase 3

Diphtheria

Mometasone furoate nasal spray (MFNS)

Phase 3

Chronic Rhinosinusitis With Nasal Polyps

LMT

Phase 3

Atherosclerotic Cardiovascular Disease

lunsekimig

Phase 3

Chronic Rhinosinusitis With Nasal Polyps

Rilzabrutinib

Phase 3

Immune Thrombocytopenia

SSR591813L (dianicline)

Phase 3

Smoking Cessation

Sotagliflozin

Phase 3

Type 2 Diabetes Mellitus

Lantus (Insulin glargine)

Phase 3

Type 2 Diabetes Mellitus

Dupilumab SAR231893 (REGN668)

Phase 3

Chronic Rhinosinusitis Phenotype With Nasal Polyps (CRSwNP)

Cytarabine

Phase 3

Acute Myeloid Leukemia

Glimepiride and Metformin hydrochloride combination (HOE490)

Phase 3

Type 2 Diabetes Mellitus

Mitoxantrone

Phase 3

Prostatic Neoplasms

Lactic acid (Dermacid)

Phase 3

Healthy

Sitagliptin

Phase 3

Type 2 Diabetes Mellitus

fexofenadine/Allegra (M016455)

Phase 3

Atopic Dermatitis

NPH insulin

Phase 3

Type 1 Diabetes Mellitus

Fexinidazole

Phase 3

Trypanosomiasis, African

Purified vero rabies vaccine - serum free - VRVg-2

Phase 3

Rabies

Insulin Glargine

Phase 3

Diabetes Mellitus Type II

clopidogrel (SR25990C)

Phase 3

Platelet Aggregation Inhibitors

Cetylpyridinium chloride

Phase 3

Hygiene

DTaP-IPV-Hep B-PRP~T combined vaccine + Pneumococcal polysaccharide

Phase 3

Diphtheria

2005-2006 trivalent inactivated influenza vaccine

Phase 3

Inactivated Influenza Vaccine

Androgen Hormonal Suppression and Radiation

Phase 3

Prostate Cancer

Epirubicin, cyclophosphamide and docetaxel

Phase 3

Breast Neoplasms

Enoxaparin sodium

Phase 3

Venous Thromboembolism

consolidation chemotherapy with Docetaxel plus cisplatin

Phase 3

Carcinoma, Non-Small-Cell Lung

Fexofenadine

Phase 3

Seasonal Allergic Rhinitis

Hexaxim™: DTaP-IPV-Hep B-PRP~T combined vaccine

Phase 3

Diphtheria

Synvisc (Hylan G-F20; hyaluronan injection)

Phase 3

Osteoarthritis

ChimeriVax-JE, Japanese Encephalitis vaccine

Phase 3

Encephalitis

REPEVAX® after REVAXIS®

Phase 3

Healthy Adult

CombAct-HIB®

Phase 3

Hepatitis B

Clopidogrel-aspirin

Phase 3

Brain Infarction

5-Fluoro-3-Pyridinecarboxylic Acid

Phase 3

Larynx Cancer

Supemtek®

Phase 3

Morbid Obesity

Alfuzosin (SL770499)

Phase 3

Urinary Retention

MabCampath-1h

Phase 3

Relapsing Remitting Multiple Sclerosis

volinanserin

Phase 3

Sleep Initiation and Maintenance Disorders

rimonabant (SR141716)

Phase 3

Obesity

vinorelbine tartrate

Phase 3

Lung Cancer

Meningococcal Group B vaccine (Trumenba®)

Phase 3

Meningococcal Immunisation (Healthy Volunteers)

Human Papillomavirus Bivalent [Types 16 and 18] Vaccine, Recombinant

Phase 3

Dengue Fever

avalglucosidase alfa

Phase 3

Glycogen Storage Disease Type II

Lactic acid (Dermacyd Femina)

Phase 3

Hygiene

Frexalimab

Phase 3

Type 1 Diabetes Mellitus

XRP6976 (Docetaxel/Taxotere)

Phase 3

Cancer

Dupilumab

Phase 3

Lichen Simplex Chronicus

Diphteria/Tetanus/Polio/Acellular Pertussis/Hib vaccine

Phase 3

Diphtheria

DOCETAXEL(XRP6976) + MODAFINIL

Phase 3

Prostatic Neoplasms

Lantus (insulin glargine injection)

Phase 3

Diabetes Mellitus

Low to medium potent topical corticosteroids

Phase 3

Neurodermatitis

Vaxigriptetra®

Phase 3

Morbid Obesity

Meningococcal group B vaccine (Bexsero®)

Phase 3

Meningococcal Immunisation (Healthy Volunteers)

alglucosidase alfa

Phase 3

Pompe Disease (Late-onset)

Meningococcal polysaccharide (serogroups A,C,Y and W) tetanus toxoid Conjugate vaccine (MenACYW Conjugate vaccine)

Phase 3

Healthy Volunteers (Meningococcal Infection)

Dupilumab/Dupixent

Phase 3

Asthma

Dermacyd PH_DETINBACK (Lactic Acid) Sweet Flower

Phase 3

Hygiene

Isatuximab IV

Phase 3

Plasma Cell Myeloma Recurrent

Generic = Plerixafor

Phase 3

Lymphoma (Non-Hodgkin's Lymphoma)

Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine (Menactra®)

Phase 3

Meningitis

DAPTACEL®: DTaP

Phase 3

Diphtheria

Dermacyd PH_DETINBACK (Lactic Acid)

Phase 3

Hygiene

Meningococcal polysaccharide (serogroups A,C,Y and W) tetanus toxoid Conjugate vaccine

Phase 3

Healthy Volunteers (Meningococcal Infection)

Piperacillin/Tazobactam

Phase 3

Pneumonia

dronedarone

Phase 3

Atrial Fibrillation

MenACYW-135 conjugate vaccine

Phase 3

Healthy Volunteers (Meningococcal Infection)

Avidin

Phase 3

Embolism

Multi-dose Quadrivalent Influenza Vaccine

Phase 3

Influenza

Thiazolidinedione (TZD)

Phase 3

Type 2 Diabetes Mellitus

SR58611A

Phase 3

Anxiety Disorders

Docetaxel (XRP6976)

Phase 3

Prostate Cancer

Lixisenatide (AVE0010)

Phase 3

Diabetes Mellitus, Type 2

Oral poliomyelitis vaccine (OPV)

Phase 3

Diphtheria

Mometasone furoate nasal spray

Phase 3

Chronic Rhinosinusitis Phenotype With Nasal Polyps (CRSwNP)

SARS-CoV-2 adjuvanted recombinant protein vaccine, bivalent (D614+B.1.351)-AS03

Phase 3

COVID-19

Hepatitis A vaccine

Phase 3

Meningococcal Immunisation

Tirapazamine

Phase 3

Head and Neck Squamous Cell Carcinoma

Leflunomide

Phase 3

Systemic Lupus Eythematosus (SLE)

Diphtheria, Tetanus, Acellular Pertussis, Poliovirus and Haemophilus b Vaccine

Phase 3

Healthy Volunteers (Meningococcal Infection)

Inactivated Poliomyelitis vaccine

Phase 3

Poliomyelitis

Tdap

Phase 3

Pregnant Women

rabbit anti-thymocyte globulin

Phase 3

Kidney Transplant Rejection

SR57746A

Phase 3

Metastases

Meningococcal Polysaccharide Diphtheria Toxoid Conjugate (Menactra®)

Phase 3

Meningococcal Infection

SARS-CoV-2 adjuvanted recombinant protein vaccine, monovalent (D614)-AS03, Dosage A

Phase 3

COVID-19

Typhoid conjugate vaccine (TCV)

Phase 3

Meningococcal Immunisation

Granulocyte colony-stimulating factor plus plerixafor

Phase 3

Lymphoma, Non-Hodgkin

Measles, Mumps, and Rubella Virus Vaccine

Phase 3

Healthy Volunteers (Meningococcal Infection)

DTaP-IPV-Hep B-PRP-T Vaccine

Phase 3

Diphtheria

rimonabant

Phase 3

Smoking Cessation

VRVg-2

Phase 3

Rabies (Healthy Volunteers)

HOE901-U300 (new formulation of insulin glargine)

Phase 3

Type 2 Diabetes Mellitus

DTaP-IPV-HB-Hib

Phase 3

Meningitis, Meningococcal

Oral Polio Vaccine

Phase 3

Diphtheria

SARS-CoV-2 recombinant protein vaccine Phase 2 Formulation 2

Phase 3

COVID-19

SARS-CoV-2 recombinant protein vaccine Phase 2 Formulation 3

Phase 3

COVID-19

SARS-CoV-2 adjuvanted recombinant protein vaccine, monovalent (B.1.351)-AS03

Phase 3

COVID-19

Measles vaccine

Phase 3

Meningococcal Immunisation

Saredutant

Phase 3

Generalized Anxiety

Varicella Virus Vaccine

Phase 3

Healthy Volunteers (Meningococcal Infection)

Dronedarone (SR33589)

Phase 3

Atrial Fibrillation

Meningococcal Polysaccharide (Serogroups A, C, Y, and W) Tetanus Toxoid Conjugate

Phase 3

Meningitis

Background therapy: Oral Anti-diabetic Drug (Metformin, Pioglitazone, SGLT2 inhibitor)

Phase 3

Type 2 Diabetes Mellitus

DTaP-IPV/Hib Combined vaccine

Phase 3

Tetanus

Purified vero rabies vaccine - serum free

Phase 3

Rabies (Healthy Volunteers)

SARS-CoV-2 adjuvanted recombinant protein vaccine, monovalent (B.1.351)-AS03 Alternative Exploratory Formulation 3

Phase 3

COVID-19

DTwP-HepB-Hib-IPV vaccine

Phase 3

Meningococcal Immunisation

Japanese encephalitis chimeric virus: Measles, mumps, and rubella live attenuated virus

Phase 3

Japanese Encephalitis

DTaP-IPV-HB-PRP~T and Pneumococcal polysaccharide vaccines

Phase 3

Hepatitis B

Hepatitis B Vaccine

Phase 3

Meningitis

Tolebrutinib

Phase 3

Primary Progressive Multiple Sclerosis

Diphtheria, tetanus, pertussis, polio, and Haemophilus influenzae vaccine

Phase 3

Dengue

Varicella

Phase 3

Meningitis, Meningococcal

SARS-CoV-2 adjuvanted recombinant protein vaccine, monovalent (B.1.351)-AS03 Alternative Exploratory Formulation 4

Phase 3

COVID-19

DTaP-IPV-Hib-HepB vaccine

Phase 3

Meningococcal Immunisation

vitamin K antagonist (warfarin or acenocoumarol) tablets

Phase 3

Atrial Fibrillation

Meningococcal group B vaccine

Phase 3

Meningococcal Immunisation

PCV13

Phase 3

Meningitis, Meningococcal

Rotavirus vaccine

Phase 3

Meningococcal Immunisation

Basal Insulin

Phase 3

Diabetes Mellitus, Type 2

Pneumococcal 13-valent Conjugate Vaccine

Phase 3

Healthy Volunteers (Meningococcal Infection)

Clopidogrel (SR25990)

Phase 3

Congenital Heart Defects

NeisVac-C

Phase 3

Neisseria Meningitidis

SARS-CoV-2 adjuvanted recombinant protein vaccine, monovalent (B.1.351)-AS03 Alternative Exploratory Formulation 2

Phase 3

COVID-19

Measles, Mumps, and Rubella Vaccine live (MMR)

Phase 3

Meningococcal Immunisation

Routine paediatric vaccine - Hepatitis A

Phase 3

Meningococcal Meningitis

MMR vaccine

Phase 3

Meningococcal Infections

RotaTeq

Phase 3

Neisseria Meningitidis

Hepatitis A Pediatric Vaccine

Phase 3

Dengue

Measles, mumps, and rubella vaccine

Phase 3

Dengue

SARS-CoV-2 adjuvanted recombinant protein vaccine, monovalent (B.1.351)-AS03 Alternative Exploratory Formulation 1

Phase 3

COVID-19

Pneumoccocal Vaccine

Phase 3

Meningococcal Immunisation

Varicella vaccine live

Phase 3

Meningococcal Immunisation

Routine paediatric vaccine - Pneumococcal conjugate (PCV)

Phase 3

Meningococcal Meningitis

AVE7688

Phase 3

Hypertension

Varicella Virus Vaccine Live

Phase 3

Meningitis

AFLIBERCEPT AVE0005

Phase 3

Colorectal Cancer Metastatic

TdcP-IPV vaccine

Phase 3

Diphtheria

pristinamycin

Phase 3

Tonsillitis

KETOPROFEN(RP19583)

Phase 3

Pain

5-fluorouracil (5-FU)

Phase 3

Head and Neck Neoplasms

Meningococcal Polysaccharide (Serogroups A, C, W, and Y) Tetanus Toxoid Conjugate Vaccine

Phase 3

Meningococcal Infection

amibegron (SR58611A)

Phase 3

Major Depressive Disorders

Neutral Protamine Hagedorn (NPH) insulin

Phase 3

Type 1 Diabetes Mellitus

Telithromycin

Phase 3

Maxillary Sinusitis

DTaP IPV HB PRP~T vaccine

Phase 3

Diphtheria

Trivalent Influenza Vaccine 2 SP Shz TIV2

Phase 3

Influenza

fexofenadine HCL (M016455)

Phase 3

Rhinitis Seasonal

Eplivanserin

Phase 3

Sleep Initiation and Maintenance Disorders

SanOrg34006

Phase 3

Deep Vein Thrombosis

20vPCV licensed vaccine

Phase 3

Pneumococcal Immunization

Measles-mumps-rubella-varicella vaccine

Phase 3

Meningococcal Meningitis

PENTAXIM™: DTacP IPV//PRP~T combined vaccine

Phase 3

Diphtheria

Measles, mumps, and rubella (MMR) vaccine

Phase 3

Dengue

DTaP-IPV-Hep B-PRP~T vaccine (Batch 1)

Phase 3

Diphtheria

DTaP- IPV-Hep B-PRP~T + Prevenar + Rotarix + Infanrix hexa vaccine

Phase 3

Diphtheria

Insulin glulisine QD

Phase 3

Type 2 Diabetes

Sevelamer Carbonate (GZ419831)

Phase 3

Hyperphosphatemia

Pneumococcal Conjugated Vaccine

Phase 3

Dengue

A/H1N1 pandemic influenza vaccine (non- adjuvanted)

Phase 3

Influenza

Rotavirus Vaccine, Live, Oral, Pentavalent

Phase 3

Pneumococcal Immunisation

M-M-RVAXPRO

Phase 3

Neisseria Meningitidis

Vandetanib

Phase 3

Non-small Cell Lung Cancer

hydroxychloroquine

Phase 3

Rheumatoid Arthritis

Meningococcal Polysaccharide Diphtheria Conjugate Vaccine

Phase 3

Meningococcal Meningitis

SR34006 (idraparinux sodium) Injection

Phase 3

Pulmonary Embolism

Haemophilus b Conjugate Vaccine

Phase 3

Healthy Volunteers (Meningococcal Infection)

Vaxelis vaccine

Phase 3

Pneumococcal Immunization

SODIUM DIVALPROATE

Phase 3

Bipolar Disorder

Sarilumab SAR153191 (REGN88)

Phase 3

Juvenile Idiopathic Arthritis

Aflibercept (ziv-aflibercept, AVE0005, VEGF trap, ZALTRAP®)

Phase 3

Pulmonary Diseases

Inhaled corticosteroid (ICS) therapy

Phase 3

Asthma

Dermacid Silver (Lactic acid)

Phase 3

Hygiene

MenACYW135 polysaccharide vaccine

Phase 3

Meningococcal Infection

Adacel® (Tetanus, Reduced Diphtheria Toxoid and Acellular Pertussis)

Phase 3

Diphtheria

Pneumococcal vaccine (10-valent)

Phase 3

Meningococcal Infections

Prevenar 13

Phase 3

Neisseria Meningitidis

Pentacel®: DTaP-IPV/Hib combined

Phase 3

Diphtheria

Menactra®: Meningococcal Polysaccharide Diphtheria Toxoid Conjugate

Phase 3

Meningitis

Influenza Virus Vaccine USP Quadrivalent (Zonal Purified Subvirion) 2012 2013 Formulation

Phase 3

Influenza

Fexofenadine (loratadine if not available)

Phase 3

Pruritus

gemcitabine/carboplatin

Phase 3

Squamous Cell Lung Cancer

DTaP-IPV-HB-Hib vaccine

Phase 3

Meningococcal Infections

Satavaptan

Phase 3

Ascites

Sevelamer carbonate

Phase 3

Chronic Kidney Disease

Diphtheria and Tetanus Toxoids and Acellular Pertussis, Hepatitis B and Inactivated Poliovirus Vaccine

Phase 3

Healthy Volunteers (Meningococcal Infection)

SAR342434

Phase 3

Type 2 Diabetes Mellitus

Hexaxim Vaccine

Phase 3

Pneumococcal Immunization

DTaP-HB-PRP~T combined vaccine

Phase 3

Diphtheria

HUMAN INSULIN (BIOSYNTHETIC)

Phase 3

Diabetes Mellitus, Type 1

Pneumococcal vaccine (13-valent)

Phase 3

Meningococcal Infections

Engerix B®

Phase 3

Hepatitis B

somatropine

Phase 3

Growth Hormone Deficiency

ticlopidine

Phase 3

Peripheral Arterial Disease (PAD)

INSULIN GLARGINE/LIXISENATIDE HOE901/AVE0010

Phase 3

Type 2 Diabetes Mellitus

Oxaliplatin (SR96669)

Phase 3

Colonic Neoplasms

ARTESUNATE + AMODIAQUINE

Phase 3

Malaria

Diphtheria and Tetanus Toxoids and Acellular Pertussis, inactivated Poliovirus and Haemophilus b Conjugate Vaccine

Phase 3

Healthy Volunteers (Meningococcal Infection)

Measles, Mumps, and Rubella Virus Vaccine Live

Phase 3

Pneumococcal Immunisation

Japanese encephalitis chimeric virus vaccine (JE-CV)

Phase 3

Encephalitis

Varivax

Phase 3

Pneumococcal Immunization

risedronate

Phase 3

Osteoporosis

MMR

Phase 3

Meningitis, Meningococcal

DTaP-IPV and ActHIB®

Phase 3

Diphtheria

Lactic Acid

Phase 3

Hygiene

ciclesonide

Phase 3

Asthma

DTaP-IPV//PRP~T combined

Phase 3

Hepatitis B

Alirocumab SAR236553 (REGN727)

Phase 3

Hypercholesterolaemia

Insuline Glulisine

Phase 3

Diabetes Mellitus, Type 1

Lipid-Modifying Therapy (LMT)

Phase 3

Hypercholesterolemia

Trivalent Influenza Vaccine 1 SP Shz TIV1

Phase 3

Influenza

2011 to 2012 Trivalent Influenza Vaccine

Phase 3

Influenza

Topical tacrolimus or pimecrolimus

Phase 3

Dermatitis Atopic

Saredutant succinate (SR48968C)

Phase 3

Depressive Disorder

Irbesartan/hydrochlorothiazide

Phase 3

Hypertension

Glimepiride+metformin (Amaryl M®) - HOE4900

Phase 3

Type 2 Diabetes Mellitus

Insulin glargine/Lixisenatide

Phase 3

Type 2 Diabetes Mellitus

tirapazamine (SR259075)

Phase 3

Head and Neck Neoplasms

Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate: Menactra®

Phase 3

Meningitis

insulin lispro protamine suspension and insulin lispro

Phase 3

Diabetes Mellitus, Type 2

Hexaxim®: DTaP-IPV-HB-PRP-T Combined Vaccine

Phase 3

Diphtheria

Insulin glulisine (HMR1964)

Phase 3

Diabetes, Type I

efanesoctocog alfa (BIVV001)

Phase 3

Hemophilia A

Belumosudil

Phase 3

Chronic Graft Versus Host Disease

Aldurazyme (Recombinant Human Alpha-L-Iduronidase)

Phase 3

Mucopolysaccharidosis I

Insulin glargine new formulation (HOE901)

Phase 3

Type 2 Diabetes Mellitus

Lactic acid (Dermacyd Femina Delicata)

Phase 3

Hygiene

Myozyme

Phase 3

Pompe Disease (Late-onset)

Lactic Acid (Dermacyd PH_DETINLYN Tangerine Mix)

Phase 3

Hygiene

sutimlimab

Phase 3

Cold Agglutinin Disease

lactoserum

Phase 3

Hygiene

Ramipril

Phase 3

Myocardial Ischemia

Poliomyelitis Vaccine inactivated

Phase 3

Poliomyelitis

DTaP-IPV-HB-PRP~T

Phase 3

Diphtheria

JE-CV administered in Study JEC02

Phase 3

Encephalitis

Hepatitis A vaccine AVAXIM

Phase 3

Hepatitis A

somatropin

Phase 3

Fetal Growth Retardation

Agalsidase beta

Phase 3

Fabry Disease

Interferon β-1a

Phase 3

Multiple Sclerosis

EMLA Cream

Phase 3

Facial Wrinkles at the Nasolabial Folds

Nirsevimab

Phase 3

RSV Immunization

Phosphatidylcholine

Phase 3

Hepatic and Hepatobiliary Disorders

Yellow fever vaccine (live)

Phase 3

Yellow Fever Immunization

Licensed 2010-2011 Trivalent Influenza Vaccine, No Preservative

Phase 3

Influenza

Inactivated Split-virion influenza vaccine

Phase 3

Orthomyxoviridae Infection

Inhaled Corticosteroid

Phase 3

Chronic Obstructive Pulmonary Disease

Dupilumab SAR231893

Phase 3

Chronic Spontaneous Urticaria

Eliglustat, GZ385660

Phase 3

Gaucher Disease

insulin glulisine/insulin glargine

Phase 3

Diabetes Mellitus, Type 1

Insulin Therapy

Phase 3

Diabetes Mellitus, Type 2

factor concentrates

Phase 3

Hemophilia A

Vaxneuvance vaccine

Phase 3

Pneumococcal Immunization

Flu-ID

Phase 3

Influenza

Thiocolchicoside+Ketoprofen

Phase 3

Low Back Pain

Bypassing agents

Phase 3

Hemophilia A

Fitusiran

Phase 3

Hemophilia

Irbesartan

Phase 3

Hypertension

sevelamer carbonate (Renvela®) sevelamer hydrochloride (Renagel ®)

Phase 3

Chronic Kidney Disease

Euvax B®: Hepatitis B vaccine

Phase 3

Hepatitis B

DT5aP-IPV-Hib 5-component Pertussis vaccine

Phase 3

Infant

MRI contrast-enhancing agents

Phase 3

Multiple Sclerosis

Open-label Semuloparin sodium

Phase 3

Venous Thromboembolism

Duvakitug

Phase 3

Ulcerative Colitis

AVANAFIL

Phase 3

Sexual Function and Fertility Disorders NEC-Erectile Dysfunction

Standard-Dose influenza virus surface antigens (haemagglutinin and neuraminidase), Inactivated, Influenza Vaccine Quadrivalent, 2019-2020 Northern Hemisphere Strains (QIV-SD)

Phase 3

Influenza Immunization

Purified inactivated rabies vaccine, serum free

Phase 3

Rabies

clofarabine (IV formulation)

Phase 3

Acute Myelogenous Leukemia

XRP6976

Phase 3

Stomach Neoplasm

HOE901-U300 (Insulin glargine new formulation)

Phase 3

Type 1 Diabetes Mellitus

enoxaparin (XRP4563)

Phase 3

Hip Fractures

Live, attenuated, recombinant dengue serotypes 1, 2, 3, & 4 virus

Phase 3

Dengue Fever

Sevelamer carbonate (Renvela®)

Phase 3

Kidney Diseases

Otamixaban

Phase 3

Acute Coronary Syndrome

DTaP-HB-PRP~T vaccine + OPV

Phase 3

Diphtheria

Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine

Phase 3

Meningococcal Meningitis

Diphtheria, tetanus, pertussis (acellular component), hepatitis B, poliomyelitis (inactivated) vaccine

Phase 3

Healthy Volunteers (Meningococcal Infection)

Riliprubart Prefilled Pen (PFP)

Phase 3

Polyneuropathy, Inflammatory Demyelinating, Chronic

Cemiplimab

Phase 3

Carcinoma, Non-Small-Cell Lung

High-Dose Quadrivalent Influenza Vaccine (Zonal Purified, Split Virus) 2020-2021 Strains (QIV-HD)

Phase 3

Influenza Immunization

insulin glulisine

Phase 3

Diabetes Mellitus

Human rotavirus RIX4414 strain vaccine

Phase 3

Healthy Volunteers (Meningococcal Infection)

Pneumococcal 13-valent polysaccharide conjugate vaccine

Phase 3

Healthy Volunteers (Meningococcal Infection)

Prednisone or Prednisolone

Phase 3

Prostatic Neoplasms

Meningococcal polysaccharide diphtheria toxoid conjugate

Phase 3

Meningitis

BPA prophylaxis

Phase 3

Hemophilia

SENNA+CASSIA

Phase 3

Constipation

Meningococcal polysaccharide group A, C, W-135 and Y Conjugate vaccine

Phase 3

Meningococcal Immunisation (Healthy Volunteers)

Sevelamer Hydrochloride (Renagel®)

Phase 3

Peritoneal Dialysis

Antihyperglycemic Drug

Phase 3

Hypercholesterolaemia

Glyburide

Phase 3

Diabetes Mellitus

Glargine insulin

Phase 3

Cystic Fibrosis Related Diabetes

DTaP-HB-PRP~T vaccine

Phase 3

Diphtheria

Riluzole

Phase 3

Huntington Disease

DTaP-IPV-Hep B-PRP~T combined vaccine

Phase 3

Diphtheria

Measles, combinations with mumps and rubella, live attenuated

Phase 3

Yellow Fever Immunization

SARS-CoV-2 adjuvanted recombinant protein vaccine (monovalent D614) (primary series)

Phase 3

COVID-19

Eliglustat tartrate

Phase 3

Gaucher Disease, Type 1

CABAZITAXEL

Phase 3

Prostate Cancer Metastatic

NVX-CoV2705

Phase 3

COVID-19

Lispro

Phase 3

Diabetes Mellitus

cabazitaxel (XRP6258) (RPR116258)

Phase 3

Neoplasms

Thyrogen + Radioiodine (131I)

Phase 3

Thyroid Neoplasms

tolevamer potassium-sodium (GT267-004)

Phase 3

Clostridium Enterocolitis

Meningococcal Polysaccharide Vaccine, Groups A, C, Y, and W-135 Combined

Phase 3

Meningitis

Teplizumab

Phase 3

Type 1 Diabetes Mellitus

Oral corticosteroid therapy (prednisone/prednisolone)

Phase 3

Asthma

ambroxol BIH1526

Phase 3

Pharyngitis

SR34006

Phase 3

Pulmonary Embolism

Live attenuated Japanese encephalitis chimeric virus vaccine (IMOJEV®)

Phase 3

Japanese Encephalitis

PCV21 vaccine

Phase 3

Pneumococcal Immunization

Non-insulin antihyperglycemic drugs

Phase 3

Type 2 Diabetes Mellitus

FEX60/PE10

Phase 3

Rhinitis Allergic

irinotecan hydrochloride

Phase 3

Colorectal Cancer

IL2

Phase 2

Prostate Cancer

XRP0038 (NV1FGF)

Phase 2

Peripheral Arterial Disease

CYD dengue vaccine serotypes (1, 2, 3, 4)

Phase 2

Dengue Virus

G-CSF Plus Plerixafor

Phase 2

Hodgkin's Disease

SAR443122

Phase 2

Colitis Ulcerative

RSV vaccine candidate

Phase 2

Respiratory Syncytial Virus Infection

SAR441344 IV

Phase 2

Systemic Lupus Erythematosus

A/C/Y/W-135, Meningococcal Polysaccharide Vaccine (Menomune®)

Phase 2

Meningitis

Oxaliplatin, Paclitaxel

Phase 2

Neoplasms, Germ Cell and Embryonal

Cabazitaxel XRP6258

Phase 2

Prostate Cancer

oxaliplatine/gemcitabine/Vinorelbine

Phase 2

Non Small Cell Lung Cancer

Menactra®: Meningococcal Polysaccharide Diphtheria Conjugate

Phase 2

Meningitis

INIPARIB + irinotecan

Phase 2

Estrogen Receptor Negative (ER-Negative) Breast Cancer

Z-1018

Phase 2

Shingles

rF1V-1018

Phase 2

Prevention of Pneumonic Plague Resulting From Aerosol Exposure to Yersenia Pestis

Sevelamer hydrochloride

Phase 2

Chronic Kidney Disease

Fludarabine Phosphate (Fludara)

Phase 2

Lymphoma

HP184

Phase 2

Spinal Cord Injury

Thymoglobulin

Phase 2

Liver Dysfunction

Live, attenuated, recombinant dengue serotypes 1, 2, 3 and 4 virus

Phase 2

Dengue Fever

Inactivated types 1, 2, and 3 poliovirus, D antigens

Phase 2

Poliomyelitis

AVE1625

Phase 2

Alzheimer Disease

SAR100842

Phase 2

Systemic Sclerosis

SAR445877

Phase 2

Solid Tumor

Clostridium difficile toxoid vaccine with adjuvant

Phase 2

Diarrhea

Monovalent Subvirion A/H1N1 Influenza vaccine

Phase 2

Influenza

Artefenomel (OZ439)

Phase 2

Plasmodium Falciparum Infection

FOLFOX regimen=oxaliplatin, fluorouracil, & folinic acid

Phase 2

Colorectal

Polysaccharide Diphtheria Toxoid Conjugate Vaccine

Phase 2

Meningococcal Meningitis

SSR150106

Phase 2

Rheumatoid Arthritis

A/H5N1 Inactivated, Split Virion Pandemic Influenza Vaccine

Phase 2

Influenza

Glatiramer Acetate (GA)

Phase 2

Multiple Sclerosis

SAR444200

Phase 2

Neoplasm

SAR161271

Phase 2

Type 1 Diabetes Mellitus

docetaxel and carboplatin

Phase 2

Lung Neoplasms

OS (oxalipaltin+S-1)

Phase 2

Colorectal Neoplasm

carmustine, etoposide, cytarabine, melphalan

Phase 2

Diffuse Large B-cell Lymphoma (DLBCL)

Chlamydia mRNA Vaccine

Phase 2

Chlamydia Trachomatis Immunization

Inactivated, split-virion influenza virus

Phase 2

Influenza

estramustine

Phase 2

Hormone Resistant Prostate Cancer

Pneumococcal Conjugate Vaccine formulation 1

Phase 2

Pneumococcal Immunisation

surinabant (SR147778)

Phase 2

Smoking Cessation

Fixed-dose combination of capecitabine and cyclophosphamide SAR439281

Phase 2

Breast Cancer Metastatic

XL147 (SAR245408)

Phase 2

Endometrial Cancer

Allogeneic DCs and Autologous RCC Tumor Derived Cells

Phase 2

Carcinoma, Renal Cell

QIV-HD by IM

Phase 2

Influenza

Interferon-β-1

Phase 2

Multiple Sclerosis

Quadrivalent Meningococcal Polysaccharide (A, C, Y, and W-135) Tetanus Protein Conjugate

Phase 2

Meningitis

Alemtuzumab plus Fludarabine

Phase 2

Leukemia, Lymphocytic, Chronic, B-Cell

Meningococcal Polysaccharide (Serogroups A, C, Y, and W135) Tetanus Toxoid Conjugate Vaccine

Phase 2

Meningitis

Brivekimig

Phase 2

Hidradenitis Suppurativa

Panblok + MF59 Dose 1

Phase 2

Influenza

XL765 (SAR245409)

Phase 2

Breast Cancer

AVE5530

Phase 2

Hypercholesterolemia

SAR3419

Phase 2

Diffuse Large B-Cell Lymphoma

Inactivated Poliomyelitis vaccine (IMOVAX)

Phase 2

Poliomyelitis

HOE140 Icatibant

Phase 2

Joint Disease

SAR407899

Phase 2

Erectile Dysfunction

High-Dose Trivalent Inactivated Influenza Vaccine

Phase 2

Influenza

Quadrivalent Influenza mRNA Vaccine MRT5407

Phase 2

Influenza Immunization

Split, Inactivated, Trivalent Influenza Vaccine (Intradermal Formulation 1)

Phase 2

Influenza

ALX-0081

Phase 2

Unstable Angina

Celivarone

Phase 2

Arrhythmia Prophylaxis

Clofarabine/Busulfan x 4

Phase 2

Leukemia

ataciguat (HMR1766)

Phase 2

Intermittent Claudication

Japanese encephalitis vaccine (Day 0) Hepatitis A vaccine (Day 28)

Phase 2

Japanese Encephalitis

Acne mRNA vaccine

Phase 2

Acne

Dupilumab SAR231893/REGN668

Phase 2

Asthma

PRN473 (SAR444727)

Phase 2

Atopic Dermatitis

Docetaxel, cisplatin and 5-FU treatment followed by concomitant cisplatin, 5-FU and radiotherapy

Phase 2

Head and Neck Neoplasms

CYD Dengue Vaccine (5 dose formulation)

Phase 2

Dengue Fever

ferroquine (SSR97193)

Phase 2

Malaria

Pneumococcal Conjugate Vaccine - formulation 1-SP0202-IIb

Phase 2

Pneumococcal Immunization

Clostridium difficile Toxoid Vaccine

Phase 2

Clostridium Difficile Infection

plerixafor GZ316455

Phase 2

Multiple Myeloma

MRrhTSH

Phase 2

Multinodular Goiter

ALX-0171

Phase 2

Respiratory Syncytial Virus Infection

Bivalent RSV+HMPV protein vaccine

Phase 2

Respiratory Syncytial Virus

ATG (Thymoglobulin)

Phase 2

Stem Cell Transplantation

Single-dose rabbit Anti-thymocyte Globulin induction

Phase 2

End-Stage Renal Disease

Docetaxel and cisplatin followed by gemcitabine

Phase 2

Carcinoma, Non-Small-Cell Lung

SAR444336

Phase 2

Microscopic Colitis

Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine

Phase 2

Meningitis

Live attenuated Japanese encephalitis virus, then ChimeriVax diluent

Phase 2

Encephalitis

SAR245408

Phase 2

Neoplasm Malignant

SSR149744C

Phase 2

Arrhythmia

SR57667B

Phase 2

Alzheimer Disease

SAR446597

Phase 2

Geographic Atrophy

DOCETAXEL(XRP6976)

Phase 2

Head and Neck Neoplasms

SL77.0499-10 (alfuzosin hydrochloride)

Phase 2

Benign Prostatic Hyperplasia

Euthyroid Group

Phase 2

Thyroid Cancer

SAR425899

Phase 2

Type 2 Diabetes Mellitus

SAR447537

Phase 2

Alpha 1-Antitrypsin Deficiency

SAR441566

Phase 2

Crohn's Disease

SAR441344

Phase 2

Sjögren's Syndrome

Anti-Thymocyte Globin (ATG)

Phase 2

Diabetes Mellitus, Type 1

Abiraterone acetate

Phase 2

Prostate Cancer

BSI-201

Phase 2

Ovarian Cancer

Influenza virus vaccine - cell based (2007-2008 Formulation)

Phase 2

Influenza

SSR240600C

Phase 2

Overactive Bladder

ChimeriVax-WN02 vaccine

Phase 2

West Nile Fever

Chimeric dengue serotype (1, 2, 3, 4)

Phase 2

Dengue

Live attenuated Japanese encephalitis virus; Yellow fever virus

Phase 2

Japanese Encephalitis

larotaxel

Phase 2

Breast Cancer

ZD6474

Phase 2

Non-Small Cell Lung Cancer (NSCLC, Locally Advanced or Metastatic, Second-line

ALX-0061

Phase 2

Lupus Erythematosus, Systemic

VEGF-receptor tyrosine kinase (KDR)

Phase 2

Multiple Myeloma

High-dose quadrivalent influenza virus vaccine

Phase 2

Influenza

Swine A/H1N1 influenza vaccine (split virion, inactivated)

Phase 2

Influenza

A/H5N1 inactivated, split-virion influenza virus

Phase 2

Influenza

ATN-103 q4wks

Phase 2

Rheumatoid Arthritis

Belumosudil (KD025)

Phase 2

Graft vs Host Disease

SSR411298

Phase 2

Major Depressive Disorder

Neulasta

Phase 2

Urothelial Carcinoma

folinic acid (dl racemic)

Phase 2

Metastatic Colorectal Cancer

Quadrivalent Influenza mRNA Vaccine MRT5421

Phase 2

Influenza Immunization

Live attenuated Japanese encephalitis virus

Phase 2

Japanese Encephalitis

GT160-246

Phase 2

Clostridium Difficile-Associated Diarrhea

Mitoguazone

Phase 2

Lymphoma, Non-Hodgkin

ATN-103

Phase 2

Rheumatoid Arthritis

SAR446268

Phase 2

Myotonic Dystrophy

RSV vaccine formulation 1

Phase 2

Respiratory Syncytial Virus Infection

ZD1839

Phase 2

Carcinoma, Non-Small-Cell Lung

Vasopressin V2 Receptor Antagonist

Phase 2

Chronic Heart Failure

Cemiplimab REGN2810

Phase 2

Plasma Cell Myeloma

IIV-HD

Phase 2

COVID-19 Immunization

GZ389988

Phase 2

Osteoarthritis

satavaptan (SR121463B)

Phase 2

Ascites

Yellow fever vaccine (produced on serum-free Vero cells)

Phase 2

Yellow Fever

Pandemic flu H5 HA mRNA SD2 vaccine

Phase 2

Pandemic Influenza Immunization

Docetaxel and Gemcitabine

Phase 2

Non-small Cell Lung Cancer

Trilostane

Phase 2

Prostate Cancer

fresolimumab

Phase 2

Primary Focal Segmental Glomerulosclerosis

Fetal porcine cells, Neurocell-PD

Phase 2

Parkinson's Disease

SAR156597

Phase 2

Idiopathic Pulmonary Fibrosis

Docetaxel + CDDP

Phase 2

Carcinoma, Squamous Cell

unfractionated heparin

Phase 2

Coronary Disease

Inactivated, split-virion, influenza vaccine

Phase 2

Influenza

Split, Inactivated, Trivalent Influenza Vaccine

Phase 2

Orthomyxoviridae Infection

Tesevatinib

Phase 2

Autosomal Dominant Polycystic Kidney

RIV (recombinant influenza vaccine)

Phase 2

COVID-19 Immunization

Isatuximab intravenous (IV)

Phase 2

Plasma Cell Myeloma

AVE0657

Phase 2

Sleep Apnea, Obstructive

Quadrivalent Inactivated Influenza High Dose

Phase 2

Influenza Immunization

Short-Acting Beta Agonists (SABA)

Phase 2

Asthma

Hybrid 5 component DTaP, Vero IPV, Hep B and PRP-OMPC

Phase 2

Diphtheria

Zemaira

Phase 2

Alpha 1-Antitrypsin Deficiency

Menactra®: Polysaccharide Diphtheria Toxoid Conjugate

Phase 2

Meningococcal Infections

Pneumococcal Conjugate Vaccine formulation 2

Phase 2

Pneumococcal Immunisation

Oxaliplatin, capecitabine

Phase 2

Rectal Neoplasms

SAR292833

Phase 2

Neuropathic Pain

Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus and Haemophilus b Conjugate (Tetanus Toxoid Conjugate)

Phase 2

Pneumococcal Immunisation

Adacel®: Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed

Phase 2

Meningitis

Vandetanib (ZD6474)

Phase 2

Advanced Breast Cancer

Pneumococcal Conjugate Vaccine formulation 3

Phase 2

Pneumococcal Immunisation

GARDASIL®: Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant

Phase 2

Meningitis

fluoropyrimidine

Phase 2

Colorectal Cancer

Purified Vero Rabies Vaccine (VRVg) - Serum Free

Phase 2

Rabies

Hepatitis B Vaccine* *as applicable

Phase 2

Pneumococcal Immunisation

Oxaliplatin + cisplatin + 5-Fluorouracil (5-FU)

Phase 2

Esophageal Neoplasms

A/H5N1 Inactivated, split-virion pandemic influenza vaccine

Phase 2

Influenza

ICS/LABA therapy

Phase 2

Asthma

Laronidase

Phase 2

Mucopolysaccharidosis I

PRV-015

Phase 2

Celiac Disease

(ADACEL®): Tetanus, Reduced Diphtheria Toxoid and Acellular Pertussis

Phase 2

Pertussis

CYD Dengue Vaccine (5-dose formulation)

Phase 2

Dengue Fever

ChimeriVax-WN02 Low Dose

Phase 2

West Nile Fever

Enteric coated sevelamer

Phase 2

Hypercholesterolemia

Influenza virus vaccine 2009-2010 formulation

Phase 2

Influenza

Inactivated rabies virus vaccine

Phase 2

Dengue Virus

Pentavalent Meningococcal ABCYW vaccine

Phase 2

Meningococcal Immunization

Live, attenuated, recombinant dengue serotype 1, 2, 3, 4 virus

Phase 2

Dengue

Rilzabrutinib dose 1

Phase 2

Graves' Disease

bsi-201 plus temozolomide

Phase 2

Glioblastoma

ILX651

Phase 2

Melanoma

recombinant human acid alpha-glucosidase (rhGAA)

Phase 2

Pompe Disease

MRT5005

Phase 2

Cystic Fibrosis

Fitusiran (SAR439774)

Phase 2

Hemophilia A

RSV/hMPV vaccine candidate Dose L

Phase 2

Respiratory Syncytial Virus Infection

Swine A/H1N1 influenza vaccine (split virion, inactivated + Adjuvant)

Phase 2

Influenza

Deferitrin (GT56-252)

Phase 2

Beta-Thalassemia

AVE2268

Phase 2

Type 2 Diabetes Mellitus

VRVg 2

Phase 2

Rabies Virus

Olipudase alfa

Phase 2

Niemann-Pick Disease

Polysaccharide Diphtheria Conjugate Vaccine

Phase 2

Meningitis

Smallpox vaccine, LISTER strain, from chick embryo cells

Phase 2

Smallpox

Tdap vaccine

Phase 2

Dermatitis Atopic

Blood draw for the laboratory assessment

Phase 2

Usher's Syndrome

oxaliplatin, 5 FU

Phase 2

Endometrial Cancer

CYD Dengue Vaccine Serotypes 1, 2, 3, and 4

Phase 2

Dengue Virus

docetaxel and cisplatin

Phase 2

Ovarian Neoplasms

acetaminophen or paracetamol

Phase 2

Osteoarthritis

FOLFIRI+aflibercept

Phase 2

Metastatic Colorectal Cancer

fixed combination of paracetamol + tramadol hydrochloride

Phase 2

Osteoarthritis

Docetaxel/Carboplatin/Bevacizumab/Erlotinib

Phase 2

Non-Small Cell Lung Cancer

fixed combination of paracetamol + codeine

Phase 2

Osteoarthritis

Genz-644470

Phase 2

Kidney Failure, Chronic

statins

Phase 2

Hypercholesterolaemia

Monovalent Subvirion A/H1N1 Influenza vaccine (of HA)

Phase 2

Influenza

Hexadecasaccharide (SR123781A)

Phase 2

Coronary Atherosclerosis

VASOPRESSIN V1B RECEPTOR ANTAGONIST (SSR149415)

Phase 2

Major Depressive Disorder

Otamixaban (XRP0673)

Phase 2

Angioplasty, Transluminal, Percutaneous Coronary

SAR442168

Phase 2

Relapsing Multiple Sclerosis

Tetanus and Diphtheria Toxoids Adsorbed Combined with Component Pertussis Vaccine and IPV

Phase 2

Pertussis

AVE1625 B

Phase 2

Obesity

Bivalent CYD-1,3 Dengue (Vero) + Bivalent CYD-2,4 Dengue (Vero)

Phase 2

Dengue Virus

Oxaliplatin, 5-FU

Phase 2

Head and Neck Cancer

alvocidib

Phase 2

Leukemia, Lymphocytic, Chronic

Zactima (vandetanib)

Phase 2

Prostate Cancer

Advate (Low Dose)

Phase 2

Hemophilia A

SSR180575

Phase 2

Diabetic Neuropathies

ZD6474, Vandetanib

Phase 2

Non Small Cell Lung Cancer

SAR444836

Phase 2

Phenylketonuria

GZ402665

Phase 2

Sphingomyelin Lipidosis

Quadrivalent Influenza mRNA Vaccine MRT5413

Phase 2

Influenza Immunization

Isatuximab SC-OBDS

Phase 2

Plasma Cell Myeloma Refractory

SAR402663

Phase 2

Neovascular Age-related Macular Degeneration

Menomune®: A, C, Y, W-135 Meningococcal Polysaccharide

Phase 2

Meningococcal Infections

Amisulpride

Phase 2

Bipolar Disorder

Haemophilus Influenzae Type b (Hib) vaccine

Phase 2

Meningitis

G-CSF and plerixafor

Phase 2

Lymphoma, Non-Hodgkin

Yellow Fever

Phase 2

Dengue

SR31747A

Phase 2

Prostatic Neoplasm

Iniparib (SAR2405550 -BSI-201)

Phase 2

Breast Cancer Female

Interferon-β

Phase 2

Multiple Sclerosis

BIVV020 (SAR445088)

Phase 2

Transplant Rejection

CoV2 preS dTM-AF03 (low-dose)

Phase 2

COVID-19 (Healthy Volunteers)

Menomune®: A, C, Y, W 135 Meningococcal Polysaccharide

Phase 2

Meningitis

SAR125844

Phase 2

Neoplasm Malignant

aminopterin

Phase 2

Leukemia

SAR445088 (IV)

Phase 2

Chronic Inflammatory Demyelinating Polyradiculoneuropathy

Trivalent (TIV) messenger ribonucleic acid (mRNA) hemagglutinin (HA) Vaccine 1

Phase 2

Influenza

anti-thymocyte globulin

Phase 2

Myelodysplastic Syndromes

Long term follow up in all patients who received SAR422459 in previous study TDU13583

Phase 2

Stargardt's Disease

sevelamer carbonate, sevelamer hydrochloride

Phase 2

Chronic Kidney Disease

Fluzone: Influenza virus vaccine

Phase 2

Influenza

Meningococcal Polysaccharide Diphtheria Protein Conjugate (Menactra®)

Phase 2

Meningitis

THOR-707

Phase 2

Oesophageal Squamous Cell Carcinoma

docetaxel and cisplatin followed by concurrent chemoradiotherapy with docetaxel and cisplatin + radiotherapy

Phase 2

Lung Neoplasms

Investigational hMPV/RSV vaccine

Phase 2

Human Metapneumovirus Immunization

Glucocorticoids

Phase 2

Immunoglobulin G4 Related Disease

SAR445399

Phase 2

Hidradenitis Suppurativa

Oxaliplatin, 5-Fluorouracil

Phase 2

Stomach Neoplasms

Thymoglobulin [Anti-Thymocyte Globulin (Rabbit)]

Phase 2

Renal Transplantation

Human Anti-Transforming Growth Factor Beta-1 Monoclonal Antibody

Phase 2

Systemic Sclerosis

Levofolinate

Phase 2

Colorectal Cancer Metastatic

Doxercalciferol

Phase 2

Moderate to Severe Chronic Plaque Psoriasis

Tetravalent CYD-1,2,3,4 Dengue (Vero)

Phase 2

Dengue Virus

SAR113945

Phase 2

Knee Osteoarthritis

Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed, Formulation 2

Phase 2

Tetanus

SAR245409

Phase 2

Lymphoma

XRP9881

Phase 2

Breast Cancer

Clostridium difficile toxoids A and B (Low-dose without adjuvant)

Phase 2

Clostridium Difficile Infection

Inactivated influenza vaccine (split virion)

Phase 2

Influenza

IRBESARTAN (SR47436)

Phase 2

Hypertension

Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed Formulation 1

Phase 2

Tetanus

Purified Vero Rabies Vaccine Serum Free (VRVg)

Phase 2

Rabies

tolterodine

Phase 2

Overactive Bladder

Plerixafor (AMD3100)

Phase 2

Lymphoma

Inactivated influenza vaccine (split virion) NH 2007-2008 formulation

Phase 2

Influenza

SAR440340

Phase 2

Asthma

Purified Vero Rabies Vaccine (VRVg)

Phase 2

Rabies

RSV vaccine candiate formulation 1

Phase 2

Respiratory Syncytial Virus Immunization

SAR110894

Phase 2

Dementia Alzheimer's Type

Oxaliplatin, capecitabine, radiotherapy

Phase 2

Rectal Neoplasms

Tetravalent CYD Dengue Vaccine, 5555 formulation

Phase 2

Dengue Fever

Docetaxel + carboplatin + radiotherapy + docetaxel + gemcitabine

Phase 2

Lung Neoplasms

Meningococcal Polysaccharide (A, C, Y, and W 135) Tetanus Protein Conjugate Vaccine

Phase 2

Meningitis

SSR125543

Phase 2

Major Depression

Pandemic flu H5 mRNA vaccine

Phase 2

Influenza Immunization

ChimeriVax™-JE vaccine

Phase 2

Japanese Encephalitis

Tetanus Toxoid Reduced Diphtheria Toxoid Acellular Pertussis

Phase 2

Dengue

Influenza virus (split virion, inactivated) vaccine

Phase 2

Influenza

MVA Smallpox vaccine

Phase 2

Smallpox

Paracetamol

Phase 2

Meningococcal Immunization

Clostridium difficile toxoids A and B (high-dose without adjuvant)

Phase 2

Clostridium Difficile Infection

Nerispirdine

Phase 2

Multiple Sclerosis

2009-2010 Trivalent Influenza Virus Vaccine

Phase 2

Influenza

SAR442970

Phase 2

Crohn's Disease

Zolpidem

Phase 2

Insomnia

Docetaxel + Oxaliplatin

Phase 2

Stomach Neoplasms

irinotecan, docetaxel

Phase 2

Gastric Cancer

Quadrivalent Influenza mRNA Vaccine MRT5424

Phase 2

Influenza Immunization

AVE2635A

Phase 2

Asthma

Clostridium difficile toxoids A and B (high-dose with adjuvant)

Phase 2

Clostridium Difficile Infection

DTap-HepB-IPV-Hib vaccine

Phase 2

Meningococcal Immunization

Tetravalent blending VDV-2/CYD-1,3,4 Dengue (Vero)

Phase 2

Dengue Virus

Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed, Formulation 3

Phase 2

Tetanus

Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed, Formulation 4

Phase 2

Tetanus

Quadrivalent Influenza mRNA Vaccine MRT5429

Phase 2

Influenza Immunization

Inactivated, split-virion, influenza virus

Phase 2

Orthomyxoviridae Infections

MenABCYW conjugate vaccine

Phase 2

Meningococcal Immunisation

S-1

Phase 2

Gastric Cancer

Clostridium difficile toxoids A and B (Low-dose with adjuvant)

Phase 2

Clostridium Difficile Infection

Alglucosidase alfa (GZ419829)

Phase 2

Glycogen Storage Disease Type II-Pompe's Disease

AERAS-404

Phase 2

Tuberculosis

PRN1008

Phase 2

Pemphigus Vulgaris

DOCETAXEL XRP6976

Phase 2

Squamous Cell Carcinoma of Head and Neck

Nolpitantium besylate

Phase 2

Ulcerative Colitis

High-Dose Quadrivalent Influenza Vaccine (QIV-HD) (split-virion, inactivated)

Phase 2

Influenza

SSR149415

Phase 2

Depressive Disorder

FOLFOX 4

Phase 2

Esophageal Neoplasms

SAR445088 (BIVV020)

Phase 2

Immune Thrombocytopenia (ITP)

Quadrivalent Influenza mRNA Vaccine MRT5410

Phase 2

Influenza Immunization

Influenza virus vaccine (2004-2005 Formulation)

Phase 2

Influenza

Split virion, inactivated Influenza vaccine

Phase 2

Influenza

Monovalent Subvirion A/H1N1 influenza vaccine with adjuvant

Phase 2

Influenza

gemcitabine plus carboplatin plus BSI-201

Phase 2

Triple Negative Breast Cancer

ARD6562, Docetaxel

Phase 2

Prostatic Neoplasms

Folic/folinic acid

Phase 2

Uveitis

Electrofusion DC vaccine

Phase 2

Renal Cell Carcinoma

drug treatment

Phase 2

Ankylosing Spondylitis

Ad2/HIF-1α/VP16

Phase 2

Intermittent Claudication

GZ/SAR402671

Phase 2

Fabry Disease

Docetaxel and Diethylstilbestrol (DES)

Phase 2

Prostate Cancer

Purified inactivated rabies vaccine

Phase 2

Rabies

Isatuximab-Irfc

Phase 2

Newly Diagnosed Multiple Myeloma

ALVAC-HIV (vCP2438)

Phase 2

HIV Infections

elranatamab

Phase 2

Relapsed Refractory Multiple Myeloma (RRMM)

AlphaMedix

Phase 2

Neuroendocrine Tumors

ALVAC-HIV

Phase 2

HIV Infection

Aflibercept + mLV5FU2

Phase 2

Colorectal Cancer

Bivalent subtype C gp120/MF59

Phase 2

HIV Infections

Alemtuzumab (Campath-1H)

Phase 2

Peripheral T-cell Lymphomas

sorafenib tosylate

Phase 2

Prostate Cancer

Cabazitaxel + Cisplatin chemotherapy

Phase 2

Infiltrating Bladder Urothelial Carcinoma

rifapentine

Phase 2

Pulmonary Tuberculosis

SAR444881

Phase 2

Solid Tumors

rabbit antithymocyte globulin

Phase 2

Aplastic Anemia

MM-121

Phase 2

ER Positive, Her2 Negative Breast Cancer Patients

Docetaxel and GM-CSF

Phase 2

Prostate Cancer

SAR441344 SC

Phase 2

Multiple Sclerosis

letrozole (Femara)

Phase 2

Breast Cancer

RSV/hMPV vaccine candidate Dose A

Phase 2

Respiratory Syncytial Virus Infection

RSV/hMPV vaccine candidate Dose B

Phase 2

Respiratory Syncytial Virus Infection

ATN-103 q8wks

Phase 2

Rheumatoid Arthritis

Clofarabine with Busulfan

Phase 2

Leukemia

sevelamer hydrochloride, sevelamer carbonate

Phase 2

Chronic Kidney Disease

Thymoglobulin (ATG)

Phase 2

Acute Myeloid Leukemia

Standard-Dose Quadrivalent Influenza Vaccine

Phase 2

Influenza

As Needed Rasburicase

Phase 2

Tumor Lysis Syndrome

Fludarabine, Mitoxantrone, Cyclophosphamide and Alemtuzumab

Phase 2

T-cell-prolymphocytic Leukemia

Bortezomib Injection

Phase 2

Multiple Myeloma

Higher-Dose Rifampin

Phase 2

Tuberculosis

Cytoxan

Phase 2

Breast Cancer

Ambroxol Hydrochloride

Phase 2

Cough

Neoadjuvant chemotherapy

Phase 2

Advanced Ovarian Cancer

FOLFOX6

Phase 2

Rectal Cancer

GC1008

Phase 2

Primary Brain Tumors

Flutamide

Phase 2

Prostate Cancer

Haploidentical donor bone marrow transplant

Phase 2

Severe Aplastic Anemia

Gemcitabine, Docetaxel, Capecitabine

Phase 2

Metastatic Pancreatic Cancer

Docetaxel/Carboplatin

Phase 2

Non-Small Cell Lung Cancer

Non pegylated liposomal doxorubicin and docetaxel

Phase 2

Breast Cancer

cetuximab and chemotherapy (docetaxel, cisplatin, 5-fluorouracil)

Phase 2

Esophageal Carcinoma

Inhaled insulin

Phase 2

Diabetes Mellitus, Type 2

Capecitabine and aflibercept

Phase 2

Metastatic Colorectal Cancer

DC/tumor fusion vaccine

Phase 2

Metastatic Melanoma

Human Rabies Immunoglobulins (HRIG)

Phase 2

Rabies Virus

CoV2 preS dTM-AF03 (high-dose)

Phase 2

COVID-19 (Healthy Volunteers)

CoV2 preS dTM (high-dose) without adjuvant

Phase 2

COVID-19 (Healthy Volunteers)

BIVV001 (High Dose)

Phase 2

Hemophilia A

paclitaxel, gemcitabine, and oxaliplatin

Phase 2

Testicular Cancer

SR141716 (Rimonabant)

Phase 2

Healthy

Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus and Haemophilus B Conjugate (Tetanus Toxoid Conjugate) Vaccine Combined (DTaP-IPV/Hib combined)

Phase 2

Meningitis

Cyclophosphamide, Doxorubicin, Vincristine and Prednisone

Phase 2

Lymphoma

BIVV001 (Low Dose)

Phase 2

Hemophilia A

rC19 (dose 1)

Phase 2

COVID-19 Immunization

RIV + rC19 (dose 4)

Phase 2

COVID-19 Immunization

M-M-RII-Measles, Mumps, and Rubella Virus Vaccine Live

Phase 2

Meningitis

Advate (High Dose)

Phase 2

Hemophilia A

nicotinic acid

Phase 2

Hypercholesterolaemia

Hepatitis A vaccine (Day 0) Japanese encephalitis vaccine (Day 28)

Phase 2

Japanese Encephalitis

VRVg 1

Phase 2

Rabies Virus

Pneumococcal 13-valent Conjugate Vaccine (Diphtheria CRM197 Protein)

Phase 2

Meningitis

Bivalent Subtype C gp120

Phase 2

HIV Infections

Imovax® Rabies: inactivated rabies vaccine

Phase 2

Rabies

omega-3 fatty acids

Phase 2

Hypercholesterolaemia

CoV2 preS dTM-AS03 (low-dose)

Phase 2

COVID-19 (Healthy Volunteers)

RIV + rC19 (dose 3)

Phase 2

COVID-19 Immunization

Pneumococcal 7-valent Conjugate Vaccine (Diphtheria CRM197 Protein)

Phase 2

Meningitis

CoV2 preS dTM-AS03 (high-dose)

Phase 2

COVID-19 (Healthy Volunteers)

Bivalent Subtype C gp120 admixed with Al(OH)3 Suspension

Phase 2

HIV Infections

RIV + rC19 (dose 1)

Phase 2

COVID-19 Immunization

RIV + rC19 (dose 2)

Phase 2

COVID-19 Immunization

Sarilumab, SAR153191 SC

Phase 2

Rheumatoid Arthritis

NPH

Phase 2

Diabetes During Pregnancy

Pimasertib once daily

Phase 2

Ovarian Cancer

Belumosudil mesylate

Phase 2

Multiple Myeloma

SR147778

Phase 2

Obesity

Meningitis

3 drugs in this indication

Dengue Virus

2 drugs in this indication

Alzheimer Disease

2 drugs in this indication

multiple myeloma

2 drugs in this indication

Diphtheria

2 drugs in this indication

Obesity

2 drugs in this indication

Hygiene

2 drugs in this indication

Non Small Cell Lung Cancer

2 drugs in this indication

Hemophilia

2 drugs in this indication

Yellow Fever Immunization

2 drugs in this indication

Type 2 Diabetes Mellitus

2 drugs in this indication

atopic dermatitis

2 drugs in this indication

COVID-19

2 drugs in this indication

Healthy Volunteers (Meningococcal Infection)

2 drugs in this indication

Systemic Sclerosis

1 drug in this indication

Diarrhea

1 drug in this indication

Pulmonary Diseases

1 drug in this indication

Juvenile Idiopathic Arthritis

1 drug in this indication

cancer

1 drug in this indication

Solid Tumor

1 drug in this indication

Hemophilia A

1 drug in this indication

Acute Urinary Retention

1 drug in this indication

Sleep Initiation and Maintenance Disorders

1 drug in this indication

Peripheral Arterial Disease

1 drug in this indication

Influenza

1 drug in this indication

Ulcerative Colitis

1 drug in this indication

Dengue

1 drug in this indication

Colitis Ulcerative

1 drug in this indication

Pompe Disease (Late-onset)

1 drug in this indication

Depressive Disorder

1 drug in this indication

IL-33 pathway

1 drug in this indication

Breast Neoplasms

1 drug in this indication

Systemic Lupus Erythematosus

1 drug in this indication

RSV Immunisation

1 drug in this indication

Seasonal Allergic Rhinitis

1 drug in this indication

Chronic Graft-versus-host-disease

1 drug in this indication

Hypercholesterolemia

1 drug in this indication

Hodgkin's Disease

1 drug in this indication

Neoplasms, Germ Cell and Embryonal

1 drug in this indication

Meningococcal Meningitis

1 drug in this indication

Prostate Cancer

1 drug in this indication

Polyneuropathy, Inflammatory Demyelinating, Chronic

1 drug in this indication

Chronic Kidney Disease

1 drug in this indication

Lymphoma

1 drug in this indication

Hemophilia B

1 drug in this indication

Spinal Cord Injury

1 drug in this indication

Immune Thrombocytopenia

1 drug in this indication

Rabies

1 drug in this indication

Lung Cancer

1 drug in this indication

Glycogen Storage Disease Type II

1 drug in this indication

Respiratory Syncytial Virus Infection

1 drug in this indication

Fabry disease

1 drug in this indication

Estrogen Receptor Negative (ER-Negative) Breast Cancer

1 drug in this indication

Rheumatoid Arthritis

1 drug in this indication

Pertussis

1 drug in this indication

eczema

1 drug in this indication

autoimmune

1 drug in this indication

diabetes

1 drug in this indication

moderate-to-severe atopic dermatitis

1 drug in this indication

Liver Dysfunction

1 drug in this indication

Dengue Fever

1 drug in this indication

Neurodermatitis

1 drug in this indication

anti-inflammation

1 drug in this indication

Active immunization against diphtheria, tetanus and pertussis in infants and children 6 weeks through 6 years of age

1 drug in this indication

immunology

1 drug in this indication

Poliomyelitis

1 drug in this indication

Meningococcal Immunisation (Healthy Volunteers)

1 drug in this indication

Atrial Fibrillation

1 drug in this indication

Major Depressive Disorders

1 drug in this indication

Shingles

1 drug in this indication

Prevention of Pneumonic Plague Resulting From Aerosol Exposure to Yersenia Pestis

1 drug in this indication

Hepatitis B

1 drug in this indication

Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)

📑
Catalyst DossierPRO
The full research note — thesis, the if-approved scenario, financials & smart money. Compiled by CeliA.
→

Frequently asked questions

What is in Sanofi's drug pipeline?→

CatalystAlert tracks 952 drug candidates in Sanofi's (SNY) pipeline across Phase 3, Phase 2. Its lead program is Venglustat (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.

When is Sanofi's next FDA catalyst?→

Sanofi's (SNY) next tracked catalyst is a PDUFA date expected Nov 25, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.

How do I track SNY biotech catalysts?→

Add SNY to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Sanofi's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.

Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply